Julia Owens: Improving Acute Stroke Care for Patients Without Timely Intervention
Julia Owens, Chief Executive Officer at Basking Biosciences Inc, reposted from Basking Biosciences, Inc. on LinkedIn:
”It was amazing to see the comprehensive neurosurgery suites recently opened and some of the state of the art tools used to intervene in critical moments.
Unfortunately many patients with acute stroke can’t get to a primary stroke center to access care fast enough or their clots aren’t accessible with thrombectomy.
At Basking we’re developing BB-031 to provide more treatment options for patients.
I am inspired daily by the work of Dr. Shahid Nimjee and others advancing new approaches to reach patients not receiving treatment today.”
Quoting Basking Biosciences, Inc.‘s post:
”Our team recently visited The Ohio State University Wexner Medical Center, where our co-founder, Dr. Shahid Nimjee, leads research on anti-vWF aptamers and their reversal agents for treating thromboembolic stroke.
As a practicing neurosurgeon, Dr. Nimjee treats stroke patients. In the lab, he studies clot biology and strategies to safely restore blood flow.
As Basking’s chief scientific officer and stroke clinical lead, he helps guide our scientific strategy and stroke clinical program.
It’s inspiring to see science in action and to work alongside such a dedicated team.
Together, we’re advancing the future of stroke care.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines